← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Masimo Corporation
Irvine, CA
$4,290,336
Total funding
2
Grants
Funding over time
peak $1M · FY2016–20$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,290,336 · 2
By mechanism
U01$2,382,844 · 1
R01$1,907,492 · 1
Investigators at Masimo Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$539,558
U01 · FY2016 · CA
MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics$519,745
R01 · FY2018 · AI
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$509,562
U01 · FY2020 · CA
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$505,567
U01 · FY2018 · CA
MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics$478,775
R01 · FY2019 · AI
MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics$478,290
R01 · FY2017 · AI
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$464,964
U01 · FY2017 · CA
MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics$430,682
R01 · FY2016 · AI
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$363,193
U01 · FY2019 · CA